Back to Companies
HALOZYME THERAPEUTICS, INC.
HALONasdaqCIK: 0001159036
HALOZYME THERAPEUTICS, INC. (HALO) shows 50 recent insider filings from 14 insiders, with all of them on the sell side. With $0 in purchases and $35.2M in sales, the recent tape is heavily weighted toward selling (net sales of $35.2M). Torley Helen (PRESIDENT AND CEO, Director) is the most active by dollar volume, and the single largest transaction was $9.8M by Snellgrove Darren. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$78.2M
Purchases
$0
Sales
$35.2M
Unique Insiders
14
Recent Insider Trades
50 loaded
| Oct 2 | HALO HALOZYME THERAPEUTICS, INC. | Posard Matthew L. | Director | Sell | $567.7K |
| Oct 2 | HALO HALOZYME THERAPEUTICS, INC. | Daly James M | Director | Grant | $189.8K |
| Oct 2 | HALO HALOZYME THERAPEUTICS, INC. | Daly James M | Director | Other | $0 |
| Sep 17 | HALO HALOZYME THERAPEUTICS, INC. | Posard Matthew L. | Director | Sell | $2.0M |
| Sep 11 | HALO HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO, Director | Sell | $6.4M |
| Sep 2 | HALO HALOZYME THERAPEUTICS, INC. | Appelhans Dannielle | Director | Grant | $191.5K |
| Aug 19 | HALO HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO, Director | Sell | $6.3M |
| Aug 21 | HALO HALOZYME THERAPEUTICS, INC. | Appelhans Dannielle | Director | Other | $0 |
| Aug 11 | HALO HALOZYME THERAPEUTICS, INC. | Connaughton Bernadette | Director | Sell | $167.2K |
| Jul 9 | HALO HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO, Director | Sell | $153.4K |
| Jul 2 | HALO HALOZYME THERAPEUTICS, INC. | Connaughton Bernadette | Director | Sell | $124.7K |
| Jul 2 | HALO HALOZYME THERAPEUTICS, INC. | Snellgrove Darren | SVP, Chief Financial Officer | Award | $9.8M |
| Jul 2 | HALO HALOZYME THERAPEUTICS, INC. | RAMSAY DAVID A | EVP, PRESIDENT, DRUG DELIVERY | Exercise | $3.5M |
| Jun 30 | HALO HALOZYME THERAPEUTICS, INC. | Krishnan Mahesh | Director | Sell | $547.8K |
| Jun 15 | HALO HALOZYME THERAPEUTICS, INC. | Snyder Mark Howard | SVP, CHIEF LEGAL OFFICER | Exercise | $188.7K |
| Jun 9 | HALO HALOZYME THERAPEUTICS, INC. | Snellgrove Darren | SVP, Chief Financial Officer | Other | $0 |
| Jun 3 | HALO HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO, Director | Sell | $3.4M |
| Jun 2 | HALO HALOZYME THERAPEUTICS, INC. | Connaughton Bernadette | Director | Sell | $107.6K |
| May 13 | HALO HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO, Director | Sell | $3.4M |
| May 7 | HALO HALOZYME THERAPEUTICS, INC. | Connaughton Bernadette | Director | Grant | $397.9K |
| May 7 | HALO HALOZYME THERAPEUTICS, INC. | DUNCAN BARBARA GAYLE | Director | Grant | $397.9K |
| May 7 | HALO HALOZYME THERAPEUTICS, INC. | Henderson Jeffrey William | Director | Grant | $397.9K |
| May 7 | HALO HALOZYME THERAPEUTICS, INC. | Lang James Paul | Director | Grant | $397.9K |
| May 7 | HALO HALOZYME THERAPEUTICS, INC. | Krishnan Mahesh | Director | Grant | $397.9K |
| May 7 | HALO HALOZYME THERAPEUTICS, INC. | Posard Matthew L. | Director | Grant | $397.9K |
| May 5 | HALO HALOZYME THERAPEUTICS, INC. | Connaughton Bernadette | Director | Sell | $103.2K |
| Apr 7 | HALO HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO, Director | Sell | $635.0K |
| Apr 2 | HALO HALOZYME THERAPEUTICS, INC. | RAMSAY DAVID A | Interim CFO | Award | $0 |
| Apr 2 | HALO HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO, Director | Sell | $2.6M |
| Mar 23 | HALO HALOZYME THERAPEUTICS, INC. | RAMSAY DAVID A | Interim CFO | Other | $0 |
| Mar 4 | HALO HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO, Director | Sell | $3.5M |
| Feb 24 | HALO HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | Exercise | $459.0K |
| Feb 24 | HALO HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO, Director | Exercise | $1.5M |
| Feb 24 | HALO HALOZYME THERAPEUTICS, INC. | Caudill Cortney | SVP, CHIEF OPERATING OFFICER | Exercise | $73.6K |
| Feb 24 | HALO HALOZYME THERAPEUTICS, INC. | Snyder Mark Howard | SVP, CHIEF LEGAL OFFICER | Exercise | $471.3K |
| Feb 17 | HALO HALOZYME THERAPEUTICS, INC. | Snyder Mark Howard | SVP, CHIEF LEGAL OFFICER | Exercise | $720.4K |
| Feb 17 | HALO HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | Exercise | $1.0M |
| Feb 17 | HALO HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO, Director | Exercise | $3.8M |
| Feb 11 | HALO HALOZYME THERAPEUTICS, INC. | Caudill Cortney | SVP, CHIEF OPERATING OFFICER | Award | $1.1M |
| Feb 11 | HALO HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO, Director | Award | $4.3M |
| Feb 11 | HALO HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | Award | $0 |
| Feb 11 | HALO HALOZYME THERAPEUTICS, INC. | Snyder Mark Howard | SVP, CHIEF LEGAL OFFICER | Award | $1.5M |
| Feb 5 | HALO HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO, Director | Sell | $3.9M |
| Jan 6 | HALO HALOZYME THERAPEUTICS, INC. | Connaughton Bernadette | Director | Sell | $140.5K |
| Jan 6 | HALO HALOZYME THERAPEUTICS, INC. | Snyder Mark Howard | SVP, CHIEF LEGAL OFFICER | Exercise | $298.3K |
| Jan 6 | HALO HALOZYME THERAPEUTICS, INC. | Lang James Paul | Director | Grant | $94.4K |
| Dec 11 | HALO HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO, Director | Award | $0 |
| Jan 5 | HALO HALOZYME THERAPEUTICS, INC. | Lang James Paul | Director | Other | $0 |
| Dec 1 | HALO HALOZYME THERAPEUTICS, INC. | Connaughton Bernadette | Director | Sell | $59.4K |
| Dec 1 | HALO HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO, Director | Sell | $1.1M |
50 filings+